<bill session="108" type="h" number="2577" updated="2013-07-14T19:01:33-04:00">
  <state datetime="2003-06-24">REFERRED</state>
  <status>
    <introduced datetime="2003-06-24"/>
  </status>
  <introduced datetime="2003-06-24"/>
  <titles>
    <title as="introduced" type="official">To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.</title>
  </titles>
  <sponsor id="400052"/>
  <cosponsors>
    <cosponsor id="400029" joined="2003-06-24"/>
    <cosponsor id="400037" joined="2003-09-17"/>
    <cosponsor id="400068" joined="2003-07-09"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-06-24">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-06-24">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2003-06-24">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2003-07-01">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
    <action datetime="2003-07-02">
      <text>Referred to the Subcommittee on Trade.</text>
      <committee name="House Ways and Means"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM04" subcommittee="Trade" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and public finance"/>
    <term name="Health"/>
    <term name="International affairs"/>
    <term name="Nontariff trade barriers"/>
    <term name="Prescription pricing"/>
    <term name="Price regulation"/>
    <term name="Trade negotiations"/>
  </subjects>
  <amendments/>
  <summary>6/24/2003--Introduced.
Requires the Comptroller General to conduct a study and report to Congress on: (1) the impact of price controls on pharmaceuticals by foreign governments, including the impact on market access for U.S. pharmaceuticals and on pharmaceutical prices for U.S. consumers; and (2) the extent to which negotiations conducted by the U.S. Trade Representative under the Bipartisan Trade Promotion Authority Act of 2002 facilitate the elimination of such price controls.</summary>
</bill>
